A Framework for Aligning 5-Year and Lifetime Breast Cancer Risk in Women Without High-Penetrance Mutations
Journal of Breast Imaging · 2026
DOI: 10.1093/jbi/wbag011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Breast Imaging, 2026. Verfasst von Graham A Colditz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Breast Cancer Research Foundation.
Abstract (Originalsprache)
Objective
Reconciling cutoff thresholds for short-term (5-year) and long-term (lifetime) breast cancer risk could support tailored and evidence-based approaches to supplemental screening and risk management most relevant to short-term clinical actions. This study aims to consistently classify women at increased risk and provide 5-year risk cutoff that corresponds to a 20% lifetime risk.
Methods
Using U.S. Surveillance, Epidemiology and End Results (SEER) program population incidence data for women 40 to 74 years of age, this study reports both lifetime and 5-year population-based risk estimates controlling for competing risk and age varying breast cancer incidence. A cut point for 5-year risk equivalent to lifetime risk of 20% which triggers increased screening is generated. This computation is a weighted average incorporating age, remaining life expectancy, and population risk distribution. The primary outcome is breast cancer incidence (in situ and invasive).
Results
A lifetime risk threshold of 20% corresponded to markedly age-dependent 5-year risk cut points, increasing from ∼1.3% at ages 40–44 to ∼10.9% at ages 70–74. For women 40–74, 20% lifetime risk corresponds to a 5-year risk cut-off of 3.16%.
Conclusions
Aligning lifetime risk of ≥20% and the 5-year breast cancer risk cutoff enhances consistency of classification of women at increased risk and clinical decision-making. Women with a ≥3.16% 5-year risk of breast cancer have risk equivalent to a lifetime risk of ≥20% on average. This can facilitate rational and evidence-based approaches to short-term and long-term risk assessment results for both risk reduction and tailored screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
- Department of Radiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
- Department of Epidemiology and Medicine, Johns Hopkins University, Baltimore, MD, USA.
- Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Förderung
- Breast Cancer Research Foundation
Zitieren
APA
Colditz, G. A., Bennett, D. L., Visvanathan, K., Rosner, B. A., & Jiang, S. (2026). A Framework for Aligning 5-Year and Lifetime Breast Cancer Risk in Women Without High-Penetrance Mutations. Journal of Breast Imaging. https://doi.org/10.1093/jbi/wbag011
Vancouver
Colditz GA, Bennett DL, Visvanathan K, Rosner BA, Jiang S. A Framework for Aligning 5-Year and Lifetime Breast Cancer Risk in Women Without High-Penetrance Mutations. Journal of Breast Imaging. 2026. doi:10.1093/jbi/wbag011
BibTeX
@article{Colditz2026,
author = {Colditz, Graham A and Bennett, Debbie L and Visvanathan, Kala and Rosner, Bernie A and Jiang, Shu},
title = {A Framework for Aligning 5-Year and Lifetime Breast Cancer Risk in Women Without High-Penetrance Mutations},
journal = {Journal of Breast Imaging},
year = {2026},
doi = {10.1093/jbi/wbag011}
}
EUVIMED